GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shanghai Runda Medical Technology Co Ltd (SHSE:603108) » Definitions » Intrinsic Value: Projected FCF

Shanghai Runda Medical Technology Co (SHSE:603108) Intrinsic Value: Projected FCF : ¥5.90 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Runda Medical Technology Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-24), Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF is ¥5.90. The stock price of Shanghai Runda Medical Technology Co is ¥17.00. Therefore, Shanghai Runda Medical Technology Co's Price-to-Intrinsic-Value-Projected-FCF of today is 2.9.

The historical rank and industry rank for Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF or its related term are showing as below:

SHSE:603108' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 2.86   Med: 10.52   Max: 27.95
Current: 2.88

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Shanghai Runda Medical Technology Co was 27.95. The lowest was 2.86. And the median was 10.52.

SHSE:603108's Price-to-Projected-FCF is ranked worse than
76.04% of 96 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.58 vs SHSE:603108: 2.88

Shanghai Runda Medical Technology Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Runda Medical Technology Co Intrinsic Value: Projected FCF Chart

Shanghai Runda Medical Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.40 2.13 1.17 5.70

Shanghai Runda Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 2.15 3.19 5.70 5.90

Competitive Comparison of Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF

For the Diagnostics & Research subindustry, Shanghai Runda Medical Technology Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Runda Medical Technology Co's Price-to-Projected-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Runda Medical Technology Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Runda Medical Technology Co's Price-to-Projected-FCF falls into.



Shanghai Runda Medical Technology Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Shanghai Runda Medical Technology Co's Free Cash Flow(6 year avg) = ¥-10.64.

Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar24)*0.8)/Shares Outstanding (Diluted Average)
=(12.018181128481*-10.63824+4323.924*0.8)/565.095
=5.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Runda Medical Technology Co  (SHSE:603108) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Shanghai Runda Medical Technology Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=17.00/5.8950918072037
=2.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Runda Medical Technology Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Runda Medical Technology Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Runda Medical Technology Co (SHSE:603108) Business Description

Traded in Other Exchanges
N/A
Address
Orient International Science & Technology Mansion, Room D-I, 15th Floor, 58 Xiangcheng Road, Pudong District, Shanghai, CHN, 200122
Shanghai Runda Medical Technology Co Ltd is a medical laboratory integrated service provider based in East China. The company provides in-vitro diagnostic products and professional technical support to various medical laboratories.
Executives
Liu Hui Directors, senior managers
Chen Zheng Directors, senior managers
Lu Xiao Yan senior management
Hu Zhen Ning Director
Wei Ming Supervisors
Tong Wen Bin Director
Xu Jing Zhi Director

Shanghai Runda Medical Technology Co (SHSE:603108) Headlines

No Headlines